Logo Logo

Publications by Knapp, Andrea

Up a level
Export as [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | Date
Jump to: 2022 | 2020 | 2019 | 2017
Number of items: 4.


Herold, Michael; Hoster, Eva ORCID: 0000-0002-0749-1389; Janssens, Ann; McCarthy, Helen; Tedeschi, Alessandra; Pocock, Chris; Rosta, Andras; Trněný, Marek; Nielsen, Tina G.; Knapp, Andrea; Hiddemann, Wolfgang; Marcus, Robert (2022): Immunochemotherapy and Maintenance With Obinutuzumab or Rituximab in Patients With Previously Untreated Marginal Zone Lymphoma in the Randomized GALLIUM Trial. In: HemaSphere, Vol. 6, No. 3, e699 [PDF, 558kB]


Mir, Farheen; Mattiello, Federico; Grigg, Andrew; Herold, Michael; Hiddemann, Wolfgang; Marcus, Robert; Seymour, John F.; Bolen, Christopher R.; Knapp, Andrea; Nielsen, Tina; Casulo, Carla (2020): Follicular Lymphoma Evaluation Index (FLEX): A new clinical prognostic model that is superior to existing risk scores for predicting progression-free survival and early treatment failure after frontline immunochemotherapy. In: American Journal of Hematology, Vol. 95, No. 12: pp. 1503-1510


Klanova, Magdalena; Oestergaard, Mikkel Z.; Trneny, Marek; Hiddemann, Wolfgang; Marcus, Robert; Sehn, Laurie H.; Vitolo, Umberto; Bazeos, Alexandra; Goede, Valentin; Zeuner, Harald; Knapp, Andrea; Sahin, Deniz; Spielewoy, Nathalie; Bolen, Christopher R.; Cardona, Andres; Klein, Christian; Venstrom, Jeffrey M.; Nielsen, Tina; Fingerle-Rowson, Guenter (2019): Prognostic Impact of Natural Killer Cell Count in Follicular Lymphoma and Diffuse Large B-cell Lymphoma Patients Treated with Immunochemotherapy. In: Clinical Cancer Research, Vol. 25, No. 15: pp. 4634-4643


Grigg, Andrew; Dyer, Martin J. S.; Gonzalez Diaz, Marcos; Dreyling, Martin; Rule, Simon; Lei, Guiyuan; Knapp, Andrea; Wassner-Fritsch, Elisabeth; Marlton, Paula (2017): Safety and efficacy of obinutuzumab with CHOP or bendamustine in previously untreated follicular lymphoma. In: Haematologica, Vol. 102, No. 4: pp. 765-772

This list was generated on Sat Apr 1 03:00:46 2023 CEST.